Lipids & metabolic liver disease

The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease

Cardiovasc DiabetolPublished Multicentre cohort study

Main finding · MACEResult — go to the resultHazard ratio 1.63 95% CI 1.14–2.35

Authors' conclusion

The TyG index might serve as a valuable and dependable indicator of MACE risk in individuals with dialysis and CAD, indicating its potential significance in enhancing risk categorization in clinical settings.

Study context

Population
Patients on dialysis (end-stage renal disease (ESRD)) with coronary artery disease (CAD), multiple centres in China, January 2015 to June 2021
Participants
959 patients
Exposure
Triglyceride-glucose (TyG) index tertiles
Outcome
MACE: composite of death from any cause, non-fatal MI and non-fatal stroke
Follow-up
1 year

Main finding

MACE

Hazard ratio

1.63

95% CI 1.14–2.35

P = 0.007

By group

Tertile 3vs Tertile 1
HR 1.63 (95% CI 1.14–2.35); P = 0.007

As reported in the abstract

Observational data: associations, not effects.

Further findings

Major adverse cardiovascular events (MACE) per unit increase in TyG index

HR per unit increase in TyG index
1.37 (95% CI 1.13-1.66, P = 0.001)

Restricted cubic spline analysis

Connection between TyG index and MACE (P for nonlinearity > 0.05)

Incremental prediction

Adding TyG index to GRACE risk score or fully adjusted baseline model considerably enhanced MACE prediction (C-statistic, continuous net reclassification improvement (NRI), integrated discrimination improvement (IDI))

Original publication

The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease. Cardiovasc Diabetol. Published 27 October 2023. doi:10.1186/s12933-023-02028-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.